4.7 Article

Bibenzyl- and stilbene-core compounds with non-polar linker atom substituents as selective ligands for estrogen receptor beta

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 44, Issue 9, Pages 3412-3424

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2009.02.006

Keywords

Estrogen receptor; Estrogen receptor beta; Stilbestrol; Hexestrol; Selective ligand

Funding

  1. National Institutes of Health [R37DK15556, P01AG024387, R01CA18119]
  2. NATIONAL CANCER INSTITUTE [R01CA018119] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK015556] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE ON AGING [P01AG024387] Funding Source: NIH RePORTER

Ask authors/readers for more resources

A series of structurally simple bibenzyl-diol and stilbene-diol core molecules, structural analogs of the well-known hexestrol and diethylstilbestrol non-steroidal estrogens, were prepared and evaluated as estrogen receptor (ER) subtype-selective ligands. Analysis of their ER alpha and ER beta binding showed that certain substitution patterns engendered binding affinities that were >100-fold selective for ER beta. When further investigated in cell-based gene transcription assays, some molecules showed similarly high relative transcriptional potency selectivity in favor of ER beta. Interestingly, the most ER beta-selective molecules were those bearing non-polar substituents on one of the internal carbon atoms. These compounds should be useful probes for determining the physiological roles of ER beta, and they might lead to the development of more selective and thus safer pharmaceuticals. (C) 2009 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available